456 related articles for article (PubMed ID: 22278422)
21. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
[TBL] [Abstract][Full Text] [Related]
22. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
[TBL] [Abstract][Full Text] [Related]
23. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Fernandes-Rosa FL; Giscos-Douriez I; Amar L; Gomez-Sanchez CE; Meatchi T; Boulkroun S; Zennaro MC
Hypertension; 2015 Nov; 66(5):1014-22. PubMed ID: 26351028
[TBL] [Abstract][Full Text] [Related]
24. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
[TBL] [Abstract][Full Text] [Related]
25. Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.
Dutta RK; Welander J; Brauckhoff M; Walz M; Alesina P; Arnesen T; Söderkvist P; Gimm O
Endocr Relat Cancer; 2014 Feb; 21(1):L1-4. PubMed ID: 24179102
[No Abstract] [Full Text] [Related]
26. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
[TBL] [Abstract][Full Text] [Related]
27. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
[TBL] [Abstract][Full Text] [Related]
28. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
29. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
30. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.
Zheng FF; Zhu LM; Nie AF; Li XY; Lin JR; Zhang K; Chen J; Zhou WL; Shen ZJ; Zhu YC; Wang JG; Zhu DL; Gao PJ
Hypertension; 2015 Mar; 65(3):622-8. PubMed ID: 25624344
[TBL] [Abstract][Full Text] [Related]
32. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
[TBL] [Abstract][Full Text] [Related]
34. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
35. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
[TBL] [Abstract][Full Text] [Related]
36. Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success.
Peng KY; Liao HW; Chan CK; Lin WC; Yang SY; Tsai YC; Huang KH; Lin YH; Chueh JS; Wu VC
Hypertension; 2020 Nov; 76(5):1537-1544. PubMed ID: 32921192
[TBL] [Abstract][Full Text] [Related]
37. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
Dekkers T; ter Meer M; Lenders JW; Hermus AR; Schultze Kool L; Langenhuijsen JF; Nishimoto K; Ogishima T; Mukai K; Azizan EA; Tops B; Deinum J; Küsters B
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1341-51. PubMed ID: 24758183
[TBL] [Abstract][Full Text] [Related]
38. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
Boulkroun S; Beuschlein F; Rossi GP; Golib-Dzib JF; Fischer E; Amar L; Mulatero P; Samson-Couterie B; Hahner S; Quinkler M; Fallo F; Letizia C; Allolio B; Ceolotto G; Cicala MV; Lang K; Lefebvre H; Lenzini L; Maniero C; Monticone S; Perrocheau M; Pilon C; Plouin PF; Rayes N; Seccia TM; Veglio F; Williams TA; Zinnamosca L; Mantero F; Benecke A; Jeunemaitre X; Reincke M; Zennaro MC
Hypertension; 2012 Mar; 59(3):592-8. PubMed ID: 22275527
[TBL] [Abstract][Full Text] [Related]
40. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
Inoue K; Yamazaki Y; Kitamoto T; Hirose R; Saito J; Omura M; Sasano H; Nishikawa T
J Clin Endocrinol Metab; 2018 Sep; 103(9):3477-3485. PubMed ID: 30020487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]